ROA surge, margin expansion, yet margin stability questioned—strong execute, investment payoff pending

Delivered ₹374.9 Cr PAT, YoY +405.2%, QoQ +21.8%

ROA at 2.18% implies Q2FY26 at ~0.69%, Q1FY27 at ~1.98%—trajectory corroborated

Net interest income ₹1,589 Cr up 13.3% QoQ, 75.6% YoY; corroborates NIM expansion

Declining cost of credit evident; Stage 3 at 1.2% (down from 1.37% Q1FY27) confirms calibration

AUM ₹74,008 Cr implies QoQ growth ~10.4%; new business traction corroborated by PRN/PPL/CV/ED scale-up

Range statement ambiguous; but pre-provisioning ₹877 Cr on ₹2625 Cr rev implies cost discipline intact

Q2FY26 ROA ~0.69% → Q2FY27 ROA 2.18%. +149 bps structural improvement validates AI/collections/risk-calibration investments. Stage 3 now 1.2% (down from 1.37% Q1FY27).

28% of disbursements from new products vs ~20% implicit prior quarter. Gold branches 90 launched; CV channels 1,250 (up from 1,100); consumer durable dealers 20,000 (up from ~12,000 implied).

9.26% NIM up 86 bps YoY despite rising borrowing costs. Portfolio yield transmission of 45+ bps over Q1FY27, driven by new product mix (higher-yield retail) and disbursement yield (+20 bps expansion).

Opex-to-AUM at 4.15% (within guidance of 10–25 bps improvement per quarter). Pre-investment phase continues; AI, collections, branch rollout absorb costs. Full payoff likely H2 FY27 onwards.

Operating leverage depends on fixed cost absorption over AUM base. Current investments in collections, branches, AI are frontloaded. Cross-sell payoff begins next phase. ROA contributions split: lending spread, NIM expansion, credit cost decline, opex leverage. All three moving in right direction; sustained growth expected.

Credit cost reached structural milestone of 2.19%, likely floor. 6 MOB 30+ cohort showing 0.35% vs 0.67% Q1FY27—32 bps improvement reflects strong recent origination quality + collections AI + Stage 2/3 compression. Portfolio seasonally improving. Expect stabilization here, slight further decline possible, but diminishing returns ahead.

New products still early stage. Gold 90 branches launched, target ~200 by year-end. Consumer durable franchise near-doubling (20k dealers). Education and CV both showing strong traction. Profitability cohort-specific—gold + durable faster, education + CV need 18–24 months. Cross-sell will unlock operating leverage (already beginning). Not offering product-level ROA yet; bundled story is the margin + opex advantage.

Pricing power strong on newer products (personal loans, digital channels); older book (gold, CDs) more rate-sensitive. 25–50 bps of pass-through already achieved in Q2 NIM; further 25 bps possible if rates stabilize. Overall portfolio yield 14.8% vs disbursement yield high; confident on continued margin expansion near-term. Long-term: prudent mix + cross-sell mitigate rate risk.

Fee mix: insurance + other service income. Insurance ~15–20% of fee base (implicit). If regulated, compression likely. Offset through: (1) cross-sell (bundled products increase per-customer economics), (2) digital channels (lower cost, higher net fee), (3) scale (opex absorption). Monitoring closely; no quantified mitigation plan yet.

Both. New originations have stricter underwriting (AI-driven early risk indicators). Existing portfolio improving via collections engine + proactive management. 12 MOB 90+ origination cohort Q1FY24 now 53% better vs portfolio; demonstrates cleaner entry. Confidence high on Stage 2 staying <1% near-term.

10.4% QoQ is run-rate sustainable; some seasonality in H2. AUM currently ₹74k Cr; 35–40% CAGR implies ₹110–130k Cr by end FY29. Feasible via: (1) retail product scale-up (gold + CV + durable + education), (2) distribution expansion (branches, digital), (3) cross-sell maturation. Margin expansion covers opex; ROA pathway credible with credit cost stable + NIM continuing to expand near-term.

Current AUM ₹74k Cr implies ₹110–130k Cr by end FY29. Anchored to retail scale-up (new products now 28% of disbursements), branch expansion (gold, CV, durable), and digital adoption. Management reaffirmed consistency with prior guidance from 2 years ago.

Current NIM 9.26% (+86 bps YoY); portfolio yield strong at 14.08%. Rate pass-through pricing power evident; ~25–50 bps further upside expected if macro stable. Opex-to-AUM at 4.15%; target compression to <4% as scale grows and AI investments normalize.

2.19% represents structural level per management; 6 MOB 30+ at 0.35% shows high-quality new originations. Provision coverage at 49.14%; risk now embedded. Downward bias unlikely; stabilization most likely.

Branch expansion funded from operations; AI capex embedded in opex. No separate capex guidance offered; implies self-funded growth model. Gold branches per-unit economics strong (high ROAE, fast turnover).

NCD at 30% of borrowing mix; cost of borrowing rose to 7.76% from 7.72% Q1FY27. Further RBI hikes (50+ bps likely over next 12 months) will compress NIM despite pricing power on newer products. Older books (gold, CDs) less rate-sensitive but smaller share.

Insurance commission likely to face regulatory attention around transparency/caps. Current fee contribution ~15–20% of fee income. If compressed, bundled product economics (cross-sell) could underperform. No explicit mitigation plan disclosed.

Credit cost at 2.19% appears structurally low; if collections slow due to macro weakness or new originations (28% of book) age poorly, Stage 3 assets (currently 1.2%) could spike. Stage 3 calibration relies on ongoing AI improvements and collections infrastructure.

28% of Q2 disbursements from new products (gold, CV, education, durable). Profitability cohort-specific: gold/durable fast (6–12 months), education/CV slow (18–24 months). If adoption slower or margins compressed by competition, ROA path to 3%+ delayed.

Opex-to-AUM at 4.15%; management targets <4% as AUM scales and AI investments normalize. If branch expansion, AI capex, or distribution buildout exceeds absorption, leverage payoff pushed into FY28. Cross-sell adoption critical; unproven at scale.